The global rise of antimicrobial resistance (AMR) and the spread of contaminants of emerging concern (CECs)—such as pharmaceuticals, pesticides, and ...

The field of functional foods increasingly focuses on the crucial role of phenolic compounds due to their well-documented ...

‎‎Professor Emmanuel Ekundayo has called on Federal government to stop paying lip service to biotechnology, but rather gear up and invest more in order to harness the full benefits in it.

Explore Vir Biotechnology (NASDAQ: VIR) operations in the healthcare sector and its presence in S&P 500, Nasdaq Composite, and Russell 1000 indexes, with detailed sector insights.

This Big Pharma could boost profits significantly in the years ahead. It’s increasingly clear that broad bets on healthcare don’t make sense as a refuge from the market chaos. Pfizer Stock’s Fall to ...

We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.

An academic has used ten of Iris Murdoch’s novels and some newly discovered poems to illuminate scientific concepts.

Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

Australian agricultural biotech company Terragen has launched its first international research trial for the company's ...

Merck & Co. has agreed to acquire Cidara Therapeutics for approximately $9.2 billion, the companies said, in a deal designed to bolster the buyer’s antiviral portfolio with a Phase III drug designed ...

Animal testing is costly, slow, and poorly predictive. ORIVA offers a human-relevant alternative with the potential to change that.

SanegeneBio, a clinical-stage biotechnology company developing RNAi therapeutics, entered a global research and licensing ...